Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-020786
Filing Date
2025-03-05
Accepted
2025-03-05 17:10:33
Documents
3
Period of Report
2025-03-05

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0233227-6k_scinai.htm 6-K 11286
2 PRESS RELEASE DATED MARCH 5, 2025 ea023322701ex99-1_scinai.htm EX-99.1 12005
3 GRAPHIC ex99-1_001.jpg GRAPHIC 9918
  Complete submission text file 0001213900-25-020786.txt   38331
Mailing Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000
Business Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000 972-8-9302529
Scinai Immunotherapeutics Ltd. (Filer) CIK: 0001611747 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37353 | Film No.: 25712330
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)